← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 31, 2014Last known activity
Aug 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Recent trials (9)
- NCT07063862Lead sponsorPhase 3Aug 31, 2025
- NCT07063862Sponsor investigatorPhase 3Aug 31, 2025
- NCT05325164CollaboratorPhase 3Sep 30, 2022
- NCT05333250CollaboratorPhase 3May 31, 2022
- NCT04754061CollaboratorPhase 1/Phase 2Mar 31, 2022
- NCT04824144Reponsible party - principal investigatorPhase 1/Phase 2Dec 31, 2021
- NCT04824144Lead sponsorPhase 1/Phase 2Dec 31, 2021
- NCT04824144Overall official - principal investigatorPhase 1/Phase 2Dec 31, 2021
- NCT02200172Lead sponsorPhase 2Dec 31, 2014
Details
- Last known activity
- Aug 31, 2025